Thompson Davis & CO. Inc. Purchases Shares of 696 Veeva Systems Inc. $VEEV

Thompson Davis & CO. Inc. acquired a new position in Veeva Systems Inc. (NYSE:VEEV) during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund acquired 696 shares of the technology company’s stock, valued at approximately $200,000.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the company. Nuveen LLC acquired a new stake in Veeva Systems in the first quarter valued at approximately $365,684,000. Price T Rowe Associates Inc. MD lifted its holdings in shares of Veeva Systems by 20.9% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 3,992,372 shares of the technology company’s stock valued at $924,754,000 after purchasing an additional 689,700 shares during the last quarter. Los Angeles Capital Management LLC boosted its position in shares of Veeva Systems by 423.8% in the 2nd quarter. Los Angeles Capital Management LLC now owns 841,303 shares of the technology company’s stock worth $242,278,000 after purchasing an additional 680,702 shares in the last quarter. Linonia Partnership LP grew its stake in Veeva Systems by 52.7% during the 1st quarter. Linonia Partnership LP now owns 1,836,557 shares of the technology company’s stock worth $425,402,000 after buying an additional 633,585 shares during the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its stake in Veeva Systems by 48.2% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,799,931 shares of the technology company’s stock worth $416,918,000 after buying an additional 585,785 shares during the last quarter. Hedge funds and other institutional investors own 88.20% of the company’s stock.

Insider Transactions at Veeva Systems

In related news, insider Eleni Nitsa Zuppas sold 6,000 shares of the firm’s stock in a transaction dated Tuesday, October 7th. The stock was sold at an average price of $306.62, for a total transaction of $1,839,720.00. Following the sale, the insider directly owned 25,325 shares of the company’s stock, valued at $7,765,151.50. This trade represents a 19.15% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, SVP Jonathan Faddis sold 720 shares of the business’s stock in a transaction that occurred on Monday, October 6th. The shares were sold at an average price of $298.12, for a total value of $214,646.40. Following the completion of the transaction, the senior vice president directly owned 7,868 shares of the company’s stock, valued at $2,345,608.16. The trade was a 8.38% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 24,665 shares of company stock worth $7,438,000 over the last quarter. 10.30% of the stock is currently owned by insiders.

Veeva Systems Price Performance

NYSE:VEEV opened at $291.75 on Friday. The company’s fifty day moving average price is $288.49 and its 200-day moving average price is $276.88. Veeva Systems Inc. has a 1-year low of $201.54 and a 1-year high of $310.50. The firm has a market capitalization of $47.82 billion, a P/E ratio of 59.91, a PEG ratio of 2.22 and a beta of 0.98.

Veeva Systems (NYSE:VEEV) last posted its quarterly earnings results on Wednesday, August 27th. The technology company reported $1.26 EPS for the quarter, missing the consensus estimate of $1.90 by ($0.64). The business had revenue of $789.08 million during the quarter, compared to analysts’ expectations of $768.49 million. Veeva Systems had a net margin of 27.29% and a return on equity of 13.72%. Veeva Systems’s revenue for the quarter was up 16.7% compared to the same quarter last year. During the same period in the previous year, the company posted $1.62 earnings per share. Veeva Systems has set its Q3 2026 guidance at 1.940-1.950 EPS. FY 2026 guidance at 7.780-7.780 EPS. Equities analysts anticipate that Veeva Systems Inc. will post 4.35 EPS for the current fiscal year.

Analyst Ratings Changes

A number of research firms have commented on VEEV. Raymond James Financial reiterated an “outperform” rating and issued a $340.00 price target (up from $310.00) on shares of Veeva Systems in a research note on Thursday, August 28th. UBS Group boosted their target price on shares of Veeva Systems from $285.00 to $310.00 and gave the stock a “neutral” rating in a research report on Thursday, August 28th. Morgan Stanley raised their price target on shares of Veeva Systems from $210.00 to $222.00 and gave the stock an “underweight” rating in a report on Thursday, August 28th. Evercore ISI lifted their price objective on shares of Veeva Systems from $285.00 to $295.00 and gave the stock an “in-line” rating in a research note on Thursday, August 28th. Finally, BTIG Research reissued a “buy” rating and issued a $340.00 target price on shares of Veeva Systems in a research report on Friday, October 17th. Seventeen research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and two have assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, Veeva Systems has a consensus rating of “Moderate Buy” and a consensus price target of $307.28.

Veeva Systems Profile

Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.